Cite

HARVARD Citation

    Ajjan, R. et al. (2022). Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. European journal of endocrinology. 186 (4), pp. 441-455. [Online]. 
  
Back to record